Geneesmiddelenbeleid
This procedure concerns a motion regarding the national policy for medicines. It aims to address how pharmaceutical products are managed, priced, or accessed to ensure the sustainability and quality of healthcare. This affects patients, healthcare providers, and pharmaceutical companies by potentially altering the availability or cost of specific medications.
National vote coverage: Netherlands-only